Acute and long-term nutrient-led modifications of gene expression: Potential role of SIRT1 as a central co-ordinator of short and longer-term programming of tissue function

Nutrition

Volumn 26, Issue 5, 2010, Pages 491-501

  Holness, Mark J ^a   Caton, Paul W ^a   Sugden, Mary C ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Developmental origins of health and adult disease; Epigenetics; Gene expression; Histone modification; Obesity; Peroxisome proliferator activated receptors; Type 2 diabetes mellitus

Indexed keywords

HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SIRTUIN 1;

ADIPOSE TISSUE; CALORIC RESTRICTION; CHROMATIN; CIRCADIAN RHYTHM; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; INSULIN RESISTANCE; LIFESPAN; LIVER FUNCTION; NONHUMAN; NUTRIGENOMICS; NUTRITIONAL STATUS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EMBRYONIC DEVELOPMENT; ENVIRONMENT; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HEALTH STATUS; HUMANS; INSULIN RESISTANCE; LIFE STYLE; MATERNAL WELFARE; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OBESITY; PPAR GAMMA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SIRTUIN 1;

EID: 77951205191     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.09.012     Document Type: Review

References (106)

1. Gicquel C., El-Osta A., Le B.Y. Epigenetic regulation and fetal programming. Best Pract Res Clin Endocrinol Metab 2008, 22:1-16.
2. Gluckman P.D., Hanson M.A., Beedle A.S. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol 2007, 19:1-19.
3. Hales C.N., Barker D.J. The thrifty phenotype hypothesis. Br Med Bull 2001, 60:5-20.
4. Burdge G.C., Hanson M.A., Slater-Jefferies J.L., Lillycrop K.A. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life?. Br J Nutr 2007, 97:1036-1046.
5. Bird A. Molecular biology. Methylation talk between histones and DNA. Science 2001, 294:2113-2115.
6. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science 2001, 293:1089-1093.
7. Biniszkiewicz D., Gribnau J., Ramsahoye B., Gaudet F., Eggan K., Humpherys D., et al. Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol 2002, 22:2124-2135.
8. Stancheva I., Meehan R.R. Transient depletion of xDnmt1 leads to premature gene activation in Xenopus embryos. Genes Dev 2000, 14:313-327.
9. Stancheva I., Hensey C., Meehan R.R. Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos. EMBO J 2001, 20:1963-1973.
10. Turner B.M. Histone acetylation and an epigenetic code. Bioessays 2000, 22:836-845.
11. Strahl B.D., Ohba R., Cook R.G., Allis C.D. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci U S A 1999, 96:14967-14972.
12. Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001, 410:116-120.
13. Zegerman P., Canas B., Pappin D., Kouzarides T. Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem 2002, 277:11621-11624.
14. Nakayama J., Rice J.C., Strahl B.D., Allis C.D., Grewal S.I. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 2001, 292:110-113.
15. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
16. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 2003, 278:4035-4040.
17. Lillycrop K.A., Phillips E.S., Jackson A.A., Hanson M.A., Burdge G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr 2005, 135:1382-1386.
18. MacLennan N.K., James S.J., Melnyk S., Piroozi A., Jernigan S., Hsu J.L., et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics 2004, 18:43-50.
19. Lillycrop K.A., Slater-Jefferies J.L., Hanson M.A., Godfrey K.M., Jackson A.A., Burdge G.C. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 2007, 97:1064-1073.
20. Burdge G.C., Lillycrop K.A., Phillips E.S., Slater-Jefferies J.L., Jackson A.A., Hanson M.A. Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J Nutr 2009, 139:1054-1060.
21. Bernal-Mizrachi C., Weng S., Feng C., Finck B.N., Knutsen R.H., Leone T.C., et al. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med 2003, 9:1069-1075.
22. Holness M.J., Langdown M.L., Sugden M.C. Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of type 2 diabetes mellitus. Biochem J 2000, 349:657-665.
23. Burdge G.C., Lillycrop K.A., Jackson A.A. Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale?. Br J Nutr 2009, 101:619-630.
24. Guarente L., Picard F. Calorie restriction-the SIR2 connection. Cell 2005, 120:473-482.
25. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305:390-392.
26. Nisoli E., Tonello C., Cardile A., Cozzi V., Bracale R., Tedesco L., et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310:314-317.
27. Civitarese A.E., Carling S., Heilbronn L.K., Hulver M.H., Ukropcova B., Deutsch W.A., et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 2007, 4:e76.
28. Chen D., Bruno J., Easlon E., Lin S.J., Cheng H.L., Alt F.W., Guarente L. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev 2008, 22:1753-1757.
29. Bordone L., Cohen D., Robinson A., Motta M.C., van Veen E., Czopik A., et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007, 6:759-767.
30. Boily G., Seifert E.L., Bevilacqua L., He X.H., Sabourin G., Estey C., et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 2008, 3:e1759.
31. Jennings B.J., Ozanne S.E., Dorling M.W., Hales C.N. Early growth determines longevity in male rats and may be related to telomere shortening in the kidney. FEBS Lett 1999, 448:4-8.
32. Ozanne S.E., Hales C.N. Lifespan: catch-up growth and obesity in male mice. Nature 2004, 427:411-412.
33. Chen J.H., Martin-Gronert M.S., Tarry-Adkins J., Ozanne S.E. Maternal protein restriction affects postnatal growth and the expression of key proteins involved in lifespan regulation in mice. PLoS One 2009, 4:e4950.
34. Grummt I., Ladurner A.G. A metabolic throttle regulates the epigenetic state of rDNA. Cell 2008, 133:577-580.
35. Pruitt K., Zinn R.L., Ohm J.E., McGarvey K.M., Kang S.H., Watkins D.N., et al. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet 2006, 2:e40.
36. Muth V., Nadaud S., Grummt I., Voit R. Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. EMBO J 2001, 20:1353-1362.
37. Murayama A., Ohmori K., Fujimura A., Minami H., Yasuzawa-Tanaka K., Kuroda T., et al. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 2008, 133:627-639.
38. Vaquero A., Scher M., Erdjument-Bromage H., Tempst P., Serrano L., Reinberg D. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature 2007, 450:440-444.
39. Dean W., Santos F., Reik W. Epigenetic reprogramming in early mammalian development and following somatic nuclear transfer. Semin Cell Dev Biol 2003, 14:93-100.
40. Waterland R.A., Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004, 20:63-68.
41. James S.J., Melnyk S., Pogribna M., Pogribny I.P., Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002, 132:2361S-2366S.
42. Ghoshal K., Li X., Datta J., Bai S., Pogribny I., Pogribny M., et al. A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J Nutr 2006, 136:1522-1527.
43. Oberdoerffer P., Michan S., McVay M., Mostoslavsky R., Vann J., Park S.K., et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 2008, 135:907-918.
44. Abdelmegeed M.A., Carruthers N.J., Woodcroft K.J., Kim S.K., Novak R.F. Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J Pharmacol Exp Ther 2005, 315:203-213.
45. Purushotham A., Schug T.T., Xu Q., Surapureddi S., Guo X., Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009, 9:327-338.
46. Feige J.N., Auwerx J. DisSIRTing on LXR and cholesterol metabolism. Cell Metab 2007, 6:343-345.
47. Lerin C., Rodgers J.T., Kalume D.E., Kim S.H., Pandey A., Puigserver P. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab 2006, 3:429-438.
48. Kelly T.J., Lerin C., Haas W., Gygi S.P., Puigserver P. GCN5-mediated Transcriptional control of the metabolic coactivator PGC-1β through lysine acetylation. J Biol Chem 2009, 284:19945-19952.
49. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
50. Teyssier C., Ma H., Emter R., Kralli A., Stallcup M.R. Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation. Genes Dev 2005, 19:1466-1473.
51. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003, 24:78-90.
52. Knutti D., Kralli A. PGC-1, a versatile coactivator. Trends Endocrinol Metab 2001, 12:360-365.
53. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
54. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
55. Burdge G.C., Lillycrop K.A., Jackson A.A., Gluckman P.D., Hanson M.A. The nature of the growth pattern and of the metabolic response to fasting in the rat are dependent upon the dietary protein and folic acid intakes of their pregnant dams and post-weaning fat consumption. Br J Nutr 2008, 99:540-549.
56. Civitarese A.E., Ravussin E. Mitochondrial energetics and insulin resistance. Endocrinology 2008, 149:950-954.
57. Zorzano A. Regulation of mitofusin-2 expression in skeletal muscle. Appl Physiol Nutr Metab 2009, 34:433-439.
58. Kelley D.E. Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest 2005, 115:1699-1702.
59. Sugden M.C., Zariwala M.G., Holness M.J. PPARs and the orchestration of metabolic fuel selection. Pharmacol Res 2009, 60:141-150.
60. Park K.S., Kim S.K., Kim M.S., Cho E.Y., Lee J.H., Lee K.U., et al. Fetal and early postnatal protein malnutrition cause long-term changes in rat liver and muscle mitochondria. J Nutr 2003, 133:3085-3090.
61. Selak M.A., Storey B.T., Peterside I., Simmons R.A. Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats. Am J Physiol Endocrinol Metab 2003, 285:E130-E137.
62. Shelley P., Martin-Gronert M.S., Rowlerson A., Poston L., Heales S.J., Hargreaves I.P., et al. Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice. Am J Physiol Regul Integr Comp Physiol 2009, 297:R675-R681.
63. Liesa M., Palacin M., Zorzano A. Mitochondrial dynamics in Mammalian health and disease. Physiol Rev 2009, 89:799-845.
64. Bach D., Naon D., Pich S., Soriano F.X., Vega N., Rieusset J., et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 2005, 54:2685-2693.
65. Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J., et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 2003, 278:17190-17197.
66. Pich S., Bach D., Briones P., Liesa M., Camps M., Testar X., et al. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 2005, 14:1405-1415.
67. Soriano F.X., Liesa M., Bach D., Chan D.C., Palacin M., Zorzano A. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes 2006, 55:1783-1791.
68. Trayhurn P., Wang B., Wood I.S. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem 2008, 114:267-276.
69. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
70. Holness M.J., Sugden M.C. Epigenetic regulation of metabolism in children born small for gestational age. Curr Opin Clin Nutr Metab Care 2006, 9:482-488.
71. Myatt L. Placental adaptive responses and fetal programming. J Physiol 2006, 572:25-30.
72. Simmons R.A. Developmental origins of diabetes: the role of oxidative stress. Free Radic Biol Med 2006, 40:917-922.
73. El-Osta A., Brasacchio D., Yao D., Pocai A., Jones P.L., Roeder R.G., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008, 205:2409-2417.
74. Yang T., Fu M., Pestell R., Sauve A.A. SIRT1 and endocrine signaling. Trends Endocrinol Metab 2006, 17:186-191.
75. Lee J.H., Song M.Y., Song E.K., Kim E.K., Moon W.S., Han M.K., et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009, 58:344-351.
76. Rosen E.D., Walkey C.J., Puigserver P., Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev 2000, 14:1293-1307.
77. Wu Z., Rosen E.D., Brun R., Hauser S., Adelmant G., Troy A.E., et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 1999, 3:151-158.
78. Fajas L., Landsberg R.L., Huss-Garcia Y., Sardet C., Lees J.A., Auwerx J. E2Fs regulate adipocyte differentiation. Dev Cell 2002, 3:39-49.
79. Miard S., Fajas L. Atypical transcriptional regulators and cofactors of PPARgamma. Int J Obes (Lond) 2005, 29(Suppl 1):S10-S12.
80. McCabe M.T., Davis J.N., Day M.L. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res 2005, 65:3624-3632.
81. Eriksson J.G. The role of genes in growth and later health. Nestle Nutr Workshop Ser Perform Programme 2008, 61:69-77.
82. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005, 308:1043-1045.
83. Doi M., Hirayama J., Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006, 125:497-508.
84. Nakahata Y., Kaluzova M., Grimaldi B., Sahar S., Hirayama J., Chen D., et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134:329-340.
85. Asher G., Gatfield D., Stratmann M., Reinke H., Dibner C., Kreppel F., et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008, 134:317-328.
86. Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007, 404:1-13.
87. Wang H., Qiang L., Farmer S.R. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol 2008, 28:188-200.
88. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429:771-776.
89. Cottrell E.C., Ozanne S.E. Early life programming of obesity and metabolic disease. Physiol Behav 2008, 94:17-28.
90. Stocker C.J., Cawthorne M.A. The influence of leptin on early life programming of obesity. Trends Biotechnol 2008, 26:545-551.
91. Petry C.J., Ozanne S.E., Hales C.N. Programming of intermediary metabolism. Mol Cell Endocrinol 2001, 185:81-91.
92. Petry C.J., Ozanne S.E., Wang C.L., Hales C.N. Effects of early protein restriction and adult obesity on rat pancreatic hormone content and glucose tolerance. Horm Metab Res 2000, 32:233-239.
93. Fernandez-Twinn D.S., Ozanne S.E. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006, 88:234-243.
94. Zhang T., Guan H., Arany E., Hill D.J., Yang K. Maternal protein restriction permanently programs adipocyte growth and development in adult male rat offspring. J Cell Biochem 2007, 101:381-388.
95. Bol V.V., Reusens B.M., Remacle C.A. Postnatal catch-up growth after fetal protein restriction programs proliferation of rat preadipocytes. Obesity (Silver Spring) 2008, 16:2760-2763.
96. Guan H.P., Li Y., Jensen M.V., Newgard C.B., Steppan C.M., Lazar M.A. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med 2002, 8:1122-1128.
97. Li G., Zhang Y., Wilsey J.T., Scarpace P.J. Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats. Diabetologia 2005, 48:2376-2385.
98. Picard F., Auwerx J. PPAR(gamma) and glucose homeostasis. Annu Rev Nutr 2002, 22:167-197.
99. Tordjman J., Khazen W., Antoine B., Chauvet G., Quette J., Fouque F., et al. Regulation of glyceroneogenesis and phosphoenolpyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes. Biochimie 2003, 85:1213-1218.
100. Ozanne S.E., Nave B.T., Wang C.L., Shepherd P.R., Prins J., Smith G.D. Poor fetal nutrition causes long-term changes in expression of insulin signaling components in adipocytes. Am J Physiol Endocrinol Metab 1997, 273:E46-E51.
101. Holness M.J. Impact of early growth retardation on glucoregulatory control and insulin action in mature rats. Am J Physiol Endocrinol Metab 1996, 270:E946-E954.
102. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
103. Tanaka M., Nozaki M., Fukuhara A., Segawa K., Aoki N., Matsuda M., et al. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem Biophys Res Commun 2007, 359:194-201.
104. Rongvaux A., Shea R.J., Mulks M.H., Gigot D., Urbain J., Leo O., Andris F. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002, 32:3225-3234.
105. Revollo J.R., Grimm A.A., Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 2004, 279:50754-50763.
106. Fulco M., Cen Y., Zhao P., Hoffman E.P., McBurney M.W., Sauve A.A., Sartorelli V. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008, 14:661-673.